Anavex Life Sciences Corp (AVXL)

[frrol]

BP has risked billions researching and testing compounds to treat AD; a tiny young biotech is far less likely to come up with something efficacious. So in the market's eyes Anavex is an unlikely winner. It has far less credibility and is treated with skepticism, which is understandable. Doesn't mean it can't, and such things have happened before. We are about to find out more in 4 days and through 2016. Patience is worth it, no? That's why it pays to be a good investor: patient, vigilant, and rational. And why market conspiracies are - if you can't concede "silly" - irrelevant.